Menu
  • Join
  • Login
  • Contact
 

FIP Development Goal 10: Equity and equality

 

 FIP Development Goal 10 Workforce Element


FIP Development Goal 10 [w]

 

                                                                                                                             

Globally, we will have:

Clear strategies for addressing equity and diversity inequalities in pharmaceutical workforce development, continued education and training, and career progression opportunities.

Mechanisms

  • Demonstration of strategies to address the equity and diversity inequalities across all pharmaceutical workforce and career development opportunities.

  • Ensure full and effective participation and equal opportunities for leadership at all levels of decision-making in pharmaceutical environments; avoidable barriers to participation for all social categories are identified and addressed.

  • Engagement and adoption of workforce development policies and enforceable legislation for the promotion of equity and equality; policies and cultures for the empowerment of all without bias.

  • This should be applicable to academic capacity and leadership development activities.

 
View the FIP Workforce Reference Guide for FIP Development Goal 10 Advanced and specialist development here.

 

FIP Development Goal 10 Practice Element


FIP Development Goal 10 [p]

 

                                                                                                                                                                   

Globally, we will have:

Clear strategies for equity and diversity in pharmaceutical services delivery, service access and service impact so that all people have access to quality pharmaceutical care.

Mechanisms

  • Develop and deliver pharmaceutical care services based on patient, population and health-system needs, taking into consideration diverse socio-economic and demographic needs and expectations. 

  • Develop and implement strategies to address equal accessibility of patients and populations to services including access to medicines and medicines information pharmaceutical workforce and medicines expertise, disease prevention (including vaccination) and public health services, and digital health services.

  • Recognise and effectively address the social determinants of health and the specific health needs of frail, vulnerable populations, and underserved communities.

  •  Ensure access by patients and populations to the pharmacy workforce across areas (e.g. urban and rural environments) and health care systems (e.g. both private and public).

  • Ensure the availability and use of service and workforce data and intelligence to understand and identify equity and equality issues and develop evidence-based policies to address them.

  • Engage patients in identifying and prioritising needs and advocate for and on behalf of those under-serviced or under-utilising services; consider acceptability of services by patients when delivering pharmaceutical care.

  • Recognise the importance of social accountability in delivering value-based healthcare. 

 

 

FIP Development Goal 10 Science Element 


FIP Development Goal 10 [s]

 

                                                                                         

Globally, we will have:

Equity in global capacity of pharmaceutical sciences training, research infrastructure, development and manufacturing capabilities, and evidence-based regulatory oversight

Mechanisms

  • Advocate for equitable career pathways to augment pharmaceutical sciences workforce in academia, industry, and regulatory bodies.

  • Monitor success of strategies implemented across the spectrum of pharmaceutical sciences to ensure sustained equity and diversity.



Find out more about the 21 FIP Development Goals for transforming global pharmacy here.
Last update 30 September 2020

FIP Congresses